Related Experiment Videos
[Written drug advertisements--are they reliable?]
Håvard Rein Solhaug1, Hanne Indermo, Lars Slørdal
1Institutt for laboratoriemedisin, barne- og kvinnesykdommer, Norges teknisk-naturvitenskapelige universitet, 7489 Trondheim.
Summary
Drug advertisements in Norway often fail to comply with national regulations. Over half of promotional claims lacked proper citations, with some being false or overly positive, diminishing their value for physicians.
Area of Science:
- Pharmaceutical Marketing
- Regulatory Compliance
- Medical Education
Background:
- Physician practice and education are influenced by pharmaceutical advertising.
- National regulations govern drug advertisements in Norway.
Purpose of the Study:
- To assess compliance of drug advertisements with Norwegian regulations.
- To evaluate the accuracy and clinical relevance of information presented in drug ads.
Main Methods:
- Collected 294 drug advertisements for 77 products over three months.
- Reviewed 50 advertisements for frequently advertised products.
- Evaluated 262 promotional claims against Norwegian regulations and reference requirements.
Main Results:
- 52% of promotional claims requiring citations did not comply with regulations.
- 6% of claims were found to be false.
- A significant proportion of claims presented an excessively positive product view.
Conclusions:
- Only half of the information in drug advertisements is accurate and clinically relevant.
- Many advertisements provide misleadingly positive information, limiting their utility.
- Ensuring regulatory compliance in drug advertising is crucial for accurate medical information dissemination.